Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q5II
|
|||
| Former ID |
DIB004102
|
|||
| Drug Name |
G009
|
|||
| Synonyms |
Beta-(1-3)-Glucan with beta-(1-6) side chain isolated from the Basidiomycetes Ganoderma lucidum
Click to Show/Hide
|
|||
| Indication | Immune System disease [ICD-11: 4A01-4B41; ICD-10: C00-C97] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lipid peroxidation (LPO) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res. 2001 May;15(3):245-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.